TREX1 in cancer immunity: from molecular mechanism to pharmacological targeting

Three-prime repair exonuclease 1 (TREX1) is a 3’→5’ exonuclease that degrades cytoplasmic DNA to prevent aberrant activation of innate immune responses. During tumorigenesis, TREX1 expression is frequently dysregulated in a cancer type-specific manner, leading to suppression of the cGAS-STING signaling pathway and reduced type I interferon (IFN-I) production, thereby facilitating tumor immune evasion in certain tumor contexts. Additionally, altered TREX1 expression is associated with chromosomal instability and cancer stem cell characteristics, promoting tumor invasion and metastasis in a context-dependent manner. Pharmacological inhibition or genetic deletion of TREX1 significantly enhances the efficacy of immune checkpoint inhibitors and STING agonists in preclinical models, indicating its potential as an immunotherapeutic target.Some inhibitors have shown selective inhibition potential against TREX1 in preclinical studies, but the selectivity for TREX2 still requires further validation. Moreover, TREX1-deficient tumor cells can serve as autologous cancer vaccines by promoting immunogenic cell death and enhancing CD8+ T cell and NK cell activation in preclinical models. This review systematically summarizes the molecular mechanisms of TREX1 in tumorigenesis and immune escape, discusses the pharmacological strategies for TREX1 targeting, and evaluates the therapeutic potential and challenges of TREX1-based immunotherapy, providing a theoretical foundation for clinical translation.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-16
DOI
https://doi.org/10.3389/fimmu.2026.1967881
Primary Topic
interferon and immune responses
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

TREX1 in cancer immunity: from molecular mechanism to pharmacological targeting

Yuanyuan Wu, Hua Shao, Lingli Huang, Wei-Lan Li
7 links
Frontiers in Immunology
interferon and immune responses
article

TREX1 in cancer immunity: from molecular mechanism to pharmacological targeting

Yuanyuan Wu, Hua Shao, Lingli Huang, Wei-Lan Li
article en

Abstract

Three-prime repair exonuclease 1 (TREX1) is a 3’→5’ exonuclease that degrades cytoplasmic DNA to prevent aberrant activation of innate immune responses. During tumorigenesis, TREX1 expression is frequently dysregulated in a cancer type-specific manner, leading to suppression of the cGAS-STING signaling pathway and reduced type I interferon (IFN-I) production, thereby facilitating tumor immune evasion in certain tumor contexts. Additionally, altered TREX1 expression is associated with chromosomal instability and cancer stem cell characteristics, promoting tumor invasion and metastasis in a context-dependent manner. Pharmacological inhibition or genetic deletion of TREX1 significantly enhances the efficacy of immune checkpoint inhibitors and STING agonists in preclinical models, indicating its potential as an immunotherapeutic target.Some inhibitors have shown selective inhibition potential against TREX1 in preclinical studies, but the selectivity for TREX2 still requires further validation. Moreover, TREX1-deficient tumor cells can serve as autologous cancer vaccines by promoting immunogenic cell death and enhancing CD8+ T cell and NK cell activation in preclinical models. This review systematically summarizes the molecular mechanisms of TREX1 in tumorigenesis and immune escape, discusses the pharmacological strategies for TREX1 targeting, and evaluates the therapeutic potential and challenges of TREX1-based immunotherapy, providing a theoretical foundation for clinical translation.

Frontiers in ImmunologyVol. 17
Zhongda Hospital Southeast University (CN), Jiangsu Cancer Hospital (CN), Nanjing Medical University (CN)
Jiangsu Cancer Hospital
Good health and well-being
interferon and immune responses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon